Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Is PacBio (PACB) Stock Soaring Today

Why Is PacBio (PACB) Stock Soaring Today

PACB : 1.7800 (+9.20%)
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

MENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced a collaboration with DNAstack to power the...

PACB : 1.7800 (+9.20%)
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 97.97 (+2.83%)
OMCL : 41.93 (+1.35%)
PACB : 1.7800 (+9.20%)
ALGN : 189.20 (+0.61%)
QDEL : 22.70 (-2.70%)
PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?

PacBio (PACB): Buy, Sell, or Hold Post Q4 Earnings?

PACB : 1.7800 (+9.20%)
5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call

5 Must-Read Analyst Questions From PacBio’s Q4 Earnings Call

PACB : 1.7800 (+9.20%)
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference 

MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate...

PACB : 1.7800 (+9.20%)
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Avoid

PACB : 1.7800 (+9.20%)
BYD : 87.71 (+3.27%)
ADP : 218.36 (+1.92%)
PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025

PacBio (NASDAQ:PACB) Reports Strong Q4 CY2025

PACB : 1.7800 (+9.20%)
Pacific Biosciences: Q4 Earnings Snapshot

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 1.7800 (+9.20%)

Barchart Exclusives

Love Dividends? 1 Stock to Buy Now With a Yield Over 6%.
Even amid volatility, Pfizer keeps rewarding shareholders year after year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar